Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,487 | -7,783 | -1,232 | -369 | -15,036 |
| Depreciation Amortization | -281 | 241 | 69 | 1 | 796 |
| Income taxes - deferred | -305 | -204 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 5,390 | -226 | 80 | 47 | 258 |
| Other Working Capital | 4,976 | -3,150 | -2,711 | 5,171 | 18 |
| Other Operating Activity | -1,709 | -5,450 | -3 | -30 | -484 |
| Operating Cash Flow | $-28,416 | $-16,572 | $-3,797 | $4,820 | $-14,448 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 32,363 | -60,347 | N/A | N/A | 0 |
| PPE Investments | -495 | -586 | -782 | -7 | -4 |
| Net Acquisitions | N/A | 31,130 | N/A | N/A | N/A |
| Purchase Sale Intangibles | 250 | N/A | 0 | N/A | N/A |
| Other Investing Activity | 250 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $32,118 | $-29,803 | $-782 | $-7 | $-4 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,000 | 0 | 0 | 11,868 |
| Debt Repayment | -1,000 | N/A | N/A | N/A | -3,139 |
| Common Stock Issued | 9 | 22 | 50 | N/A | 2 |
| Other Financing Activity | 0 | 37,666 | 10,925 | 610 | 32,435 |
| Financing Cash Flow | $-991 | $42,688 | $10,975 | $610 | $41,166 |
| Beginning Cash Position | 8,132 | 11,819 | 5,423 | N/A | 1,098 |
| End Cash Position | 10,843 | 8,132 | 11,819 | 5,423 | 27,812 |
| Net Cash Flow | $2,711 | $-3,687 | $6,396 | $5,423 | $26,714 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,416 | -16,572 | -3,797 | 4,820 | -14,448 |
| Capital Expenditure | -495 | -586 | -782 | -7 | -4 |
| Free Cash Flow | -28,911 | -17,158 | -4,579 | 4,813 | -14,452 |